SCHEMBL13792172

SCHEMBL13792172

CCCn1c(CCCc2ccc(O)cc2)cn(Cc2ccc(Cl)c(Cl)c2)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HTT P42858 2/20 0.38
UBE2N P61088 1/20 0.38
SIGMAR1 Q99720 3/20 0.38
LIPG Q9Y5X9 3/20 0.37
LIPC P11150 2/20 0.37
MAPT P10636 3/20 0.37
GAA P10253 2/20 0.37
PROKR1 Q8TCW9 1/20 0.37
TP53 P04637 2/20 0.37
ABCB11 O95342 2/20 0.36
CCR2 P41597 1/20 0.36
SRC P12931 1/20 0.36
PRKACA P17612 1/20 0.36
PRKACG P22612 1/20 0.36
PRKACB P22694 1/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13792793 0.88 ADORA3 (0.39) LMNATP53CYP3A4CYP1A2CYP2C9
SCHEMBL13792168 0.88 PROKR1 (0.43) LMNASMN1; SMN2HTTUBE2NMAPT
SCHEMBL13793078 0.88 EGLN1 (0.41) LMNASMN1; SMN2HTTUBE2NMAPT
SCHEMBL13793151 0.87 L3MBTL1 (0.41) LMNATP53CYP3A4ESR1ADRA2A
SCHEMBL13793030 0.87 PPARA (0.43) LMNAMAPTTP53CYP3A4ESR1
SCHEMBL13793100 0.86 ADORA3 (0.36) LMNAMAPTTP53CYP3A4ESR1
SCHEMBL13793029 0.86 PPARG (0.38) LMNAMAPTTP53CYP3A4CYP1A2
SCHEMBL13792786 0.86 L3MBTL1 (0.42) LMNATP53CYP3A4ESR1ADRA2A
SCHEMBL13792820 0.85 ADORA2A (0.40) LMNAMAPTTP53CYP3A4ESR1
SCHEMBL13793031 0.84 UTS2R (0.38) LMNASMN1; SMN2TP53CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 US disclosed
US-7544812-B2 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus ELI LILLY AND COMPANY (US) 2009-06-09 US disclosed